Neurology | Kiddy Ume, MD June 02, 2025 | 0.75 Credits | 24:48

The goal of this program is to improve diagnosis and management of new-onset refractory status epilepticus (NORSE). After hearing and assimilating this program, the clinician will be better able to:

1. Perform a diagnostic workup for a patient with suspected NORSE.
2. Administer recommended first- and second-line therapies for patients with NORSE.

Gastroenterology | Christopher Bowlus, MD June 02, 2025 | 1.00 Credits | 27:53

The goal of this program is to improve diagnosis and management of cholangitis. After hearing and assimilating this program, the clinician will be better able to:

1. Describe the association between primary sclerosing cholangitis and inflammatory bowel disease.
2. Diagnose overlap of primary biliary cholangitis and autoimmune hepatitis.
3. Compare the efficacy of different agents designed to alleviate pruritus in patients with cholestatic liver disease.

Gastroenterology | Alan Moss, MD June 02, 2025 | 1.00 Credits | 30:19

The goal of this program is to improve screening for asymptomatic inflammatory bowel disease. After hearing and assimilating this program, the clinician will be better able to:

1. Assess the types of complications that occur independently of remissions and flares in patients with Crohn disease.
2. Evaluate the preclinical cellular, microbiome, and leaky gut changes that may develop in individuals who are at high risk for Crohn disease.

Otolaryngology | Michelle Wilson, MA June 02, 2025 | 0.50 Credits | 13:40

The goal of this program is to improve management of dysphagia with expiratory muscle strength training (EMST). After hearing and assimilating this program, the clinician will be better able to:

1. Compare outcomes among EMST devices.
2. Improve swallow safety in patients using EMST.

Otolaryngology | Sandeep Kunwar, MD June 02, 2025 | 1.00 Credits | 32:35

The goal of this program is to improve the management of craniopharyngioma. After hearing and assimilating this program, the clinician will be better able to:

1. Use BRAF inhibitors plus MEK inhibitors in papillary craniopharyngioma.
2. Optimize use of subtotal resection plus radiotherapy in management of craniopharyngioma.

Oncology | Rebecca Shatsky, MD June 02, 2025 | 1.00 Credits | 32:42

The goal of this program is to improve the management of breast cancer using antibody drug conjugates (ADCs). After hearing and assimilating this program, the clinician will be better able to:

1. Implement appropriate ADC therapy for patients with HER2-positive breast cancer and brain metastases.
2. Cite evidence from the ASCENT trial regarding outcomes in patients with triple-negative breast cancer.
3. Explain the recommendation regarding testing for resistance mutations in ADCs.

Ophthalmology | Paula Anne Newman-Casey, MD, MS June 02, 2025 | 0.75 Credits | 24:55

The goal of this program is to improve management of glaucoma medication adherence. After hearing and assimilating this program, the clinician will be better able to:

1. Recognize the types and reasons for poor glaucoma medication adherence.
2. Outline the impact of poor glaucoma medication adherence.

Oncology | Tim Whelan, MD June 02, 2025 | 0.75 Credits | 26:06

The goal of this program is to improve patient outcomes through evaluation of the omission of radiation therapy in the management of early breast cancer. After hearing and assimilating this program, the clinician will be better able to:

1. List common adverse effects associated with radiation therapy in breast cancer.
2. Appraise available evidence on omission of radiation therapy in early-stage breast cancer.

Ophthalmology | Sunita Radhakrishnan, MD June 02, 2025 | 0.25 Credits | 10:43

The goal of this program is to improve management of glaucoma through neurostimulation. After hearing and assimilating this program, the clinician will be better able to:

1. Evaluate the efficacy of neurostimulation in enhancing neural function in glaucoma.

Ophthalmology | Ta Chen (Peter) Chang, MD, Craig McKeown, MD June 02, 2025 | 0.50 Credits | 14:45

The goal of this program is to improve management of inadvertent vitreous staining and complex lacrimal choristoma. After hearing and assimilating this program, the clinician will be better able to:

1. Identify inadvertent vitreous staining and complex lacrimal choristoma.